Literature DB >> 1573642

Bis(maltolato)oxovanadium(IV) is a potent insulin mimic.

J H McNeill1, V G Yuen, H R Hoveyda, C Orvig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573642     DOI: 10.1021/jm00086a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  34 in total

Review 1.  Anti-diabetic and toxic effects of vanadium compounds.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.

Authors:  Debbie C Crans; Boyan Zhang; Ernestas Gaidamauskas; Anastasios D Keramidas; Gail R Willsky; Chris R Roberts
Journal:  Inorg Chem       Date:  2010-05-03       Impact factor: 5.165

Review 3.  Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats.

Authors:  S Bhanot; A Michoulas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 4.  The chemistry of peroxovanadium compounds relevant to insulin mimesis.

Authors:  A Shaver; J B Ng; D A Hall; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.

Authors:  D C Crans; M Mahroof-Tahir; A D Keramidas
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 6.  Increased potency of vanadium using organic ligands.

Authors:  J H McNeill; V G Yuen; S Dai; C Orvig
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 7.  Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.

Authors:  J L Domingo; M Gomez; D J Sanchez; J M Llobet; C L Keen
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

8.  A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.

Authors:  Navasona Krishnan; Konstantis F Konidaris; Gilles Gasser; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

Review 9.  Vanadium and diabetes.

Authors:  P Poucheret; S Verma; M D Grynpas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.

Authors:  Kenji Kawabe; Takahiro Sasagawa; Yutaka Yoshikawa; Akio Ichimura; Katsumi Kumekawa; Naohisa Yanagihara; Toshikazu Takino; Hiromu Sakurai; Yoshitane Kojima
Journal:  J Biol Inorg Chem       Date:  2003-10-09       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.